Lundbeck
HLUN-B.CO
$4.73
Share price
0.00%
Change (1 day)
-9.73%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Earnings for Lundbeck (HLUN-B.CO)
Earnings in 2023 (TTM): $0.44 B
According to Lundbeck 's latest financial reports the company's current earnings (TTM) are $0.44 B. In 2022 the company made an earning of $0.36 B an increase over its 2021 earnings that were of $0.27 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lundbeck from 2009 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.44 B | 21.69% |
| 2022 | $0.36 B | 31.79% |
| 2021 | $0.27 B | -4.53% |
| 2020 | $0.28 B | -45.08% |
| 2019 | $0.52 B | -33.97% |
| 2018 | $0.79 B | 12.76% |
| 2017 | $0.70 B | 94.32% |
| 2016 | $0.36 B | -136.98% |
| 2015 | -$0.99 B | -1258.1% |
| 2014 | $84.76 M | -72.43% |
| 2013 | $0.30 B | 4.31% |
| 2012 | $0.29 B | -55.26% |
| 2011 | $0.65 B | 6.64% |
| 2010 | $0.61 B | -6.68% |
| 2009 | $0.66 B |